Citations

Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4784 total record number 156 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 462 out of 479
4784 citations found

Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins

Wang, S;Li, H;Chen, Y;Wei, H;Gao, GF;Liu, H;Huang, S;Chen, JL;

Product: Toxin B from Clostridium difficile

  • Antibodies and Reagents:

    Clostridium difficile toxin B was obtained from List Biological Laboratories (Campbell, CA). …

    Rho Family GTPases Are Required for Efficient Transport of Influenza A Virus NA to Cell Surface:

    … Next, we used this established system to investigate the contribution of Rho GTPases to influenza virus NA transport to the cell surface. Rho-GTPase activity was acutely inhibited in cells treated with C. difficile toxin B, as toxin B glucosylates all members of the Rho family and inhibits their effector interactions (30, 40,,42). …
    To further confirm these observations, we used an independent approach to test the effects of toxin B on NA transport to the plasma membranes. …

Therapeutic effects of systemic administration of chaperone B-crystallin associated with binding proinflammatory plasma proteins

Rothbard, JB;Kurnellas, MP;Brownell, S;Adams, CM;Su, L;Axtell, RC;Chen, R;Fathman, CG;Robinson, WH;Steinman, L;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Anthrax lethal toxin disrupts intestinal barrier function and causes systemic infections with enteric bacteria

Sun, C;Fang, H;Xie, T;Auth, RD;Patel, N;Murray, PR;Snoy, PJ;Frucht, DM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

I-domain-antigen conjugate (IDAC) for delivering antigenic peptides to APC: synthesis, characterization, and in vivo EAE suppression

Manikwar, P;Byktimkin, B;Kiptoo, P;Badawi, AH;Galeva, NA;Williams, TD;Siahaan, TJ;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection

Friedman-Levi, Y;Hoftberger, R;Budka, H;Mayer-Sonnenfeld, T;Abramsky, O;Ovadia, H;Gabizon, R;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Identification of cellular infiltrates during early stages of brain inflammation with magnetic resonance microscopy

Waiczies, H;Millward, JM;Lepore, S;Infante-Duarte, C;Pohlmann, A;Niendorf, T;Waiczies, S;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Sometimes it takes two to tango: contributions of dimerization to functions of human -defensin HNP1 peptide

Pazgier, M;Wei, G;Ericksen, B;Jung, G;Wu, Z;de Leeuw, E;Yuan, W;Szmacinski, H;Lu, WY;Lubkowski, J;Lehrer, RI;Lu, W;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

PI3K/Akt contributes to increased expression of Toll-like receptor 4 in macrophages exposed to hypoxic stress

Kim, SY;Jeong, E;Joung, SM;Lee, JY;

Product: Unspecified List Labs LPS

Maximal Adjuvant Activity of Nasally Delivered IL-1a Requires Adjuvant-Responsive CD11c+ Cells and Does Not Correlate with Adjuvant-Induced In Vivo Cytokine Production

Thompson, AL;Johnson, BT;Sempowski, GD;Gunn, MD;Hou, B;DeFranco, AL;Staats, HF;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • Nasal vaccination:

    Mice were anesthetized with isourane before vaccination. Vaccines were administered intranasally in 10 ml (5ml per nostril). Nonchimeric mice were vaccinated on days 0, 7, and 21. Chimeric mice were vaccinated on days 0, 7, 21, and 42. For each chimeric study replicate, mice were divided into groups of 4 to 8. Vaccine groups included PBS alone, recombinant LF (rLF) alone (#172; List Biological Laboratories Cambell, CA; 4 endotoxin units [EU]/mg), rLF + 4 mg IL-1a (400-ML; 0.00144 EU/mg; R&D, Minneapolis, MN), and rLF + 1 mg cholera toxin (CT) (EU/mg unknown; List #100B). For three of the four Il1r1 chimeric mouse experiments, mice were vaccinated with 25 mg LF for the day 0, 7, and 21 immunizations and 50 mg LF on day 42. For the remaining experiment, mice were immunized with 50 mg LF each time. The calculated endotoxin delivery per mouse was 0.20 (LF alone) to 0.22 EU (LF + IL-1a). Data from each group for all repeat experiments were combined and analyzed together. Mice vaccinated with LF + CT served as a positive control, and LF + CT-vaccinated mice responded similarly in all four chimeric groups.

Maximal adjuvant activity of nasally delivered IL-1 requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production

Thompson, AL;Johnson, BT;Sempowski, GD;Gunn, MD;Hou, B;DeFranco, AL;Staats, HF;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • Nasal vaccination:

    Mice were anesthetized with isourane before vaccination. Vaccines were administered intranasally in 10 ml (5ml per nostril). Nonchimeric mice were vaccinated on days 0, 7, and 21. Chimeric mice were vaccinated on days 0, 7, 21, and 42. For each chimeric study replicate, mice were divided into groups of 4 to 8. Vaccine groups included PBS alone, recombinant LF (rLF) alone (#172; List Biological Laboratories Cambell, CA; 4 endotoxin units [EU]/mg), rLF + 4 mg IL-1a (400-ML; 0.00144 EU/mg; R&D, Minneapolis, MN), and rLF + 1 mg cholera toxin (CT) (EU/mg unknown; List #100B). For three of the four Il1r1 chimeric mouse experiments, mice were vaccinated with 25 mg LF for the day 0, 7, and 21 immunizations and 50 mg LF on day 42. For the remaining experiment, mice were immunized with 50 mg LF each time. The calculated endotoxin delivery per mouse was 0.20 (LF alone) to 0.22 EU (LF + IL-1a). Data from each group for all repeat experiments were combined and analyzed together. Mice vaccinated with LF + CT served as a positive control, and LF + CT-vaccinated mice responded similarly in all four chimeric groups. …